Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Linn

Showing results (151-160 of 467) with videos related to

Pageof 47
Sort By:
Trials|June 22, 2016
A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trialPhilip C Schouten, Gwen M H E Dackus, Serena Marchetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
Breast cancers with a BRCA1-like DNA copy number profile recur less often than expected after high-dose alkylating chemotherapyPhilip C Schouten, Frederik Marmé, Sebastian Aulmann, et al.
British Journal of Cancer|March 4, 1998
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancerA H Honkoop, P J van Diest, J S de Jong, et al.
Psycho-Oncology|June 11, 2009
The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapyChristina M Schilder, Caroline Seynaeve, Sabine C Linn, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|May 26, 2023
Ingesta-associated choledocholithiasis in horses: 2 cases and literature reviewSarah C Linn-Peirano, Kate Hepworth-Warren, Hannah Kinsella, et al.
Journal of Clinical Immunology|March 1, 1984
Thermostable erythrocyte rosette-forming lymphocytes in hereditary hemochromatosis. I. Identification in peripheral bloodC F Bryan, S H Leech, R Ducos, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2020
PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestaneDinja T Kruger, Mark Opdam, Vincent van der Noort, et al.
BMC Cancer|January 7, 2023
High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementationJoost G E Verbeek, Vincent M T de Jong, Hanna M Wijnja, et al.
International Journal of Cancer|May 29, 1997
Expression of drug resistance proteins in breast cancer, in relation to chemotherapyS C Linn, H M Pinedo, J van Ark-Otte, et al.
American Journal of Clinical Pathology|February 1, 1997
Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancerA H Honkoop, H M Pinedo, J S De Jong, et al.
Pageof 47

Showing results (151-160 of 467) with videos related to

Sort By:
Pageof 47
Trials|June 22, 2016
A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trialPhilip C Schouten, Gwen M H E Dackus, Serena Marchetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2014
Breast cancers with a BRCA1-like DNA copy number profile recur less often than expected after high-dose alkylating chemotherapyPhilip C Schouten, Frederik Marmé, Sebastian Aulmann, et al.
British Journal of Cancer|March 4, 1998
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancerA H Honkoop, P J van Diest, J S de Jong, et al.
Psycho-Oncology|June 11, 2009
The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapyChristina M Schilder, Caroline Seynaeve, Sabine C Linn, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|May 26, 2023
Ingesta-associated choledocholithiasis in horses: 2 cases and literature reviewSarah C Linn-Peirano, Kate Hepworth-Warren, Hannah Kinsella, et al.
Journal of Clinical Immunology|March 1, 1984
Thermostable erythrocyte rosette-forming lymphocytes in hereditary hemochromatosis. I. Identification in peripheral bloodC F Bryan, S H Leech, R Ducos, et al.
Journal of Cancer Research and Clinical Oncology|June 23, 2020
PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestaneDinja T Kruger, Mark Opdam, Vincent van der Noort, et al.
BMC Cancer|January 7, 2023
High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementationJoost G E Verbeek, Vincent M T de Jong, Hanna M Wijnja, et al.
International Journal of Cancer|May 29, 1997
Expression of drug resistance proteins in breast cancer, in relation to chemotherapyS C Linn, H M Pinedo, J van Ark-Otte, et al.
American Journal of Clinical Pathology|February 1, 1997
Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancerA H Honkoop, H M Pinedo, J S De Jong, et al.
Pageof 47